Posted by AROME webmaster on January 10, 2013 Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider. Tsoutsou PG, Belkacemi Y, Gligorov J, Kuten A, Boussen H, Bese …
Posted by AROME webmaster on January 10, 2013 Post mastectomy radiation for large node negative breast cancer: Time for a second look.Boutrus R, Taghian AG; on behalf of AROME. Crit Rev Oncol Hematol. 2010 Nov 5.PMID:21115360
Posted by AROME webmaster on January 10, 2013 Controversies in loco-regional treatment: Post-mastectomy radiation for pT2-pT3N0 breast cancer arguments in favour. Valli MC; on behalf of AROME. Crit Rev Oncol Hematol. 2010 Dec 4.PMID:21134765
Posted by AROME webmaster on January 10, 2013 Combined hormone therapy and radiation therapy for locally advanced prostate cancer.Bolla M, Laramas M; on behalf of AROME. Crit Rev Oncol Hematol. 2010 Dec 8.PMID:21144766
Posted by AROME webmaster on January 10, 2013 Future challenges in head and neck cancer: From the bench to the bedside? Calabrese L, Ostuni A, Ansarin M, Giugliano G, Maffini F, Alterio D, Rocca MC, Petralia G, Bruschini...
Posted by AROME webmaster on January 10, 2013 Larynx preservation: What is the standard treatment? Horn S, Ozsahin M, Lefèbvre JL, Horiot JC, Lartigau E; on behalf of AROME. Crit Rev Oncol Hematol. 2010 Dec 23. PMID:21185198
Biologic tools to personalize treatment in genitourinary cancers. Bracarda S, Sisani M, Del Buono S, Ishiwa O, Montagnani F; on behalf of AROME. Crit Rev Oncol Hematol. 2011 Jan 12. PMID:21232974] http://download.journals.elsevierhealth.com/pdfs/journals/1040-8428/PIIS1040842810002222.pdf by AROME webmaster, 10 Jan 2013
Controversies in the management of localized prostate cancer: Radical prostatectomy still the standard of care. Budäus L, Huland H, Graefen M; on behalf of AROME, Association of Radiotherapy and Oncology of the Mediterranean arEa. Crit Rev Oncol Hematol. 2011 May 23. PMID:21612943 by AROME webmaster, 10 Jan 2013
Secondary malignancies in survivors of breast cancer: How to overcome the risk. Shilkrut M, Belkacemi Y, Kuten A; on behalf of AROME. Crit Rev Oncol Hematol. 2011 Nov 6. PMID:22056996 by AROME webmaster, 10 Jan 2013
First data on direct costs of lung cancer management in Morocco. Tachfouti N, Belkacemi Y, Raherison C, Bekkali R, Benider A, Nejjari C. Asian Pac J Cancer Prev. 2012;13(4):1547-51. PMID: 22799364 by AROME webmaster, 10 Jan 2013